Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg. Celecoxib is a nonsteroidal ...

TCS promoters owned 71.77 per cent stake, or 2,59,65,58,628 shares in TCS at the end of March quarter, as per latest filing.